Pharmaids Pharmaceuticals Ltd

Pharmaids_Pharma21 Jun 2024
Pharmaceuticals
+1.21 (+2.41%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Pharmaids Pharma
Pharmaids Pharmaceuticals Ltd
Pharmaceuticals
Pharmaids_Pharma21 Jun 2024
+1.21 (+2.41%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Pharmaids Pharma - Share Price & Details

Lowest Today
50
Highest Today
51.99
Today’s Open
51.99
Prev. Close
50.17
52 Week High
79.23
52 Week Low
31.79
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
55.37%
Upper Circuit
Lower Circuit
P/E TTM
0
P/B Ratio
2.55
Traded Value(Cr)
0.00
EPS TTM
0
Book value
Dividend
0.00%

Price Performance

-1.21 %
1 Wk
-13.85 %
1 M
-4.05 %
3 M
55.37 %
1 Y
0.53 %
YTD

Traded Volume Movement

Technical Details

Support 3
0
Support 2
0
Support 1
0
Pivot Point :
0
Resistance 1
0
Resistance 2
0
Resistance 3
0

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Pharmaids Pharmaceuticals Ltd
₹51.38(+1.21/2.41%)
51.38+1.21181.2155.370.002.55
Astrazeneca Pharma India Ltd
₹6,350.95(-24.05/-0.38%)
6,350.95-24.0515,877.3872.61106.2022.30
Cipla Ltd
₹1,540.95(-3.50/-0.23%)
1,540.95-3.50124,423.3552.7733.504.45
Bliss GVS Pharma Ltd
₹103.90(+0.90/0.87%)
103.90+0.901,088.2225.8214.351.10
Amrutanjan Health Care Ltd
₹751.50(-7.00/-0.92%)
751.50-7.002,172.6321.5748.307.53
Abbott India Ltd
₹26,843.60(-60.65/-0.23%)
26,843.60-60.6557,042.6518.3347.4915.42

About Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 181.21 crores. It has reported a sales of Rs. 0.01 crores and a net profit of Rs. -2.24 crores for the quarter ended December 2018. The company management includes Shankarappa Nagaraja Vinaya Babu, Venu Madhava Kaparthy,Mini Manikantan,Sadhanala Venkata Rao,P N Vijay,M Sudheer Anand,Methuku Nagesh,Shreedhara Shetty,Sadhanala Venkata Rao,Shankarappa Nagaraja Vinaya Babu (Pharmaids Pharmaceuticals Ltd) among others.
Chairman
Shankarappa Nagaraja Vinaya Babu
Registered office
4-4-211/212/3 1st Floor,Inderbagh Sulthan Bazar,Hyderabad,Telangana,500095
FAX :91-40-23232348
Background
Incorporation Year1989
Face Value₹10
Market Lot1

Latest News

Nifty Bank surges over 3% to mark biggest weekly gain in 2024
The Indian market ended the week with fluctuations, but the Nifty Bank index posted a 3.32% gain, its best weekly performance in 2024, driven by a rebound in heavyweights like Bandhan Bank, IDFC Bank, and HDFC Bank. Analysts attribute the gain to robust foreign portfolio investor inflows and profit booking in other sectors.
21 Jun 2024 | 10:09 PM
Tech View: Nifty chart shows bearish candle formation
Indian equity indices fell on Friday, ending a six-session gaining streak, with the Nifty 50-stock index closing at 23,501.10, down 0.28%. The decline was driven by index heavyweights Reliance Industries and Larsen & Toubro. Analysts predict a range-bound trade for the remaining June series, with support at 23,300 and resistance at 23,700-23,740. A move above 23,600 could take the index to 24,000.
21 Jun 2024 | 07:52 PM
📢 Sensex declines 269 points at the close; Nifty ends around 23,500
📈 Domestic benchmark indices closed on a negative note on 21 June, 2024.
📢 At 3:30 PM, the Sensex tanked by 269.03 points or 0.35% at 77,209.90, and the Nifty was down 65.90 points or 0.28% at 23,501.10.
📊Among sectoral, Nifty IT (⬆️0.76%) turned out to be the best performer while Nifty FMCG (⬇️1.20%) saw considerable selling.
21 Jun 2024 | 03:39 PM
Stock market strategy- Deploy ‘buy on dips’: ICICI Securities
Indian benchmark indices, Sensex and Nifty 50, traded 0.5% lower each on Friday. Despite a drop last month, the market has stabilized this month, with the Nifty index showing 10% topline and 12.4% bottom-line growth in Q4FY24. ICICI Securities expects Nifty earnings to grow at a CAGR of 16.9% over FY23-26E, valuing Nifty at 25,000, i.e., 20x PE on FY26E Nifty EPS of ₹1,250.
21 Jun 2024 | 01:26 PM
Nifty IT up on Accenture’s strong inorganic growth and acquisition spree
Accenture's Q3 results sparked a 2.7% surge in the Nifty IT index, reaching an intraday high of 35,875.30. The company reported $16.47 billion in revenue, a 1% Y/Y decrease, and revised its full-year revenue guidance to 1.5%-2.5% growth. Despite this, Accenture's strong booking growth and raised inorganic growth guidance boosted investor sentiment.
21 Jun 2024 | 12:41 PM

How to buy Pharmaids Pharma shares on nse?

To buy Pharmaids Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Pharmaids Pharma share price today?

The Pharmaids Pharma shares price on nse is Rs.51.38 today.

What is the market cap of Pharmaids Pharma shares on BSE ?

The company has a market capitalization of Rs.181.21Cr

What is the PE & PB ratio of Pharmaids Pharma shares ?

PE is 0 and PB is 2.55

What is the 52 Week High and Low of Pharmaids Pharma shares?

Pharmaids Pharma stock price high: Rs.79.23 Pharmaids Pharma stock price low: Rs.31.79